The project entitled Neuro-Laser, in which two CI-NAPS teams are actively involved, has recently been granted support from the regional “Emergence” fund.

The aim of the project, which falls within the framework of a three-party partnership between CI-NAPS biologists and chemists and CIMAP physicists, is to develop an imaging platform for fluorescence microscopy to study NMDA glutamate receptors on cellular models reproducing the pathological conditions observed during many neurodegenerative diseases.

The Gallimed project, focusing on the development and the validation of new radiopharmaceuticals and involving Cyceron, the CI-Naps’ GDM-TEP - Positron Emission Tomography Methodology Development Group, and the pharmaceutical companies Nordion and Guebert, was awarded the Eureka label on the 16th of October.

Send post as PDF to